Technicien de production
About the job
- Training at Bac to Bac+2 level in a scientific, quality, laboratory, or biochemistry field.
- A first experience in the pharmaceutical industry.
- Knowledge of good manufacturing practices.
- Rigor, responsiveness, and ability to prioritize.
- Clean equipment and premises.
- Manage orders and consumption through the enterprise resource planning system.
- Prepare the necessary materials and equipment, including monitoring automated systems, checking validity and compliance, and assembling equipment.
- Perform first-level maintenance.
- Review batch records.
- Monitor critical parameters such as temperature, volumes, flow rates, and clean-in-place processes.
- Carry out process and/or cleaning qualification and validation activities.
- Raise an alert when a problem occurs in operating an automated system.
About the company
LFB is a French biopharmaceutical company that develops and manufactures medicines from plasma and biotech products. It collects plasma, fractionates it into medicines, and also produces recombinant proteins for rare diseases in immunology and hemostasis, sold in many countries. It stands out because it started as a state-initiated public health mission and remains state-owned with the French State as sole shareholder, plus vertical integration through acquisitions of plasma collection firms. Its goal is to ensure a reliable supply of essential medicines for public health while growing as a global biopharma player.
Company Size
1,001-5,000
Company Stage
N/A
Total Funding
N/A
Headquarters
Courcebœufs, France
Founded
1994
Get referred to LFB
See people who can refer or advise you
Simplify's Take
What believers are saying
- Arras released first medicines in 2025, proving commercialization after heavy capital spending.
- LFB signed a 2026 collaboration with Sartorius to accelerate client programs and GMP manufacturing.
- France 2030 funding and the 2026 Alès expansion add capacity and roughly fifty jobs.
What critics are saying
- EFS must raise plasma collections to 1.4 million liters by 2028 or Arras underutilizes.
- LFB BIOMANUFACTURING still depends on Sartorius for cell line development, limiting full-stack control.
- A single French industrial base creates existential exposure to contamination, recalls, or regulatory shutdowns.
What makes LFB unique
- French state-owned sole domestic plasma fractionator anchors national medicine supply.
- Arras plant, authorized in 2025, centralizes production and triples plasma-derived capacity.
- Europlasma and Amber Plasma give LFB 24 Central European collection centers.
Help us improve and share your feedback! Did you find this helpful?
Benefits
- Health Insurance
- 401(k) Retirement Plan
- Remote Work Options
- Unlimited Paid Time Off
- Flexible Work Hours
- Paid Vacation
- Hybrid Work Options
- Wellness Program
- Mental Health Support
- Phone/Internet Stipend
- Home Office Stipend
- Stock Options